(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

P+AAV

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

P+AAV

ST13

US500000079360999

Class

1

Filing

79360999

Registration

7095625

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

13

Latest update

12/12/2025

Classification

Registered

Trademark type

Word

Nice classes

1

Filing date

11/28/2022

Registration date

07/04/2023

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/04/2023

Last transaction

12/12/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

33

Owner location

FR

Examiner

RAFARI-PEARSON, NIYA

Law office

M30

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

P. T. (pessoa física)

Representatives

Cabinet Nuss, Monsieur Olivier Girard

Technical classification

Nice Classes

Class 1

Vienna Codes

No Vienna codes available.

Goods and services

Class 1

Biological preparations and substances for scientific and research usein particular in the field of genetics; biological preparations and substances for scientific and research useDNA and DNA plasmids; biological preparations and substances used for development and manufacture of gene therapy productspharmaceutical products or vaccines; biological preparations and substances for development and manufacture of gene therapy productspharmaceutical products or vaccinesDNA and DNA plasmids

Publications

History of USPTO decisions and trademark events.

13 publications found

NREP

NEW REPRESENTATIVE AT IB RECEIVED

12/11/2025

GPNX

NOTIFICATION PROCESSED BY IB

08/27/2023

FICS

FINAL DISPOSITION NOTICE SENT TO IB

08/10/2023

FIMP

FINAL DISPOSITION PROCESSED

08/10/2023

GPAR

GRANT OF PROTECTION CREATED, TO BE SENT TO IB

08/03/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

07/04/2023

PUBO

PUBLISHED FOR OPPOSITION

04/18/2023

NPUB

NOTICE OF PUBLICATION

03/29/2023

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/13/2023

DOCK

ASSIGNED TO EXAMINER

03/03/2023

MAFR

APPLICATION FILING RECEIPT MAILED

01/31/2023

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

01/27/2023

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

01/26/2023

Continuous trademark protection

Get notified about every new filing that threatens P+AAV or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.